Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 5

Review Article

An Overview of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Formula Granules

Table 5

Comparison of the effectiveness rate between CHM formula granules and placebo based on conventional therapy.

Study IDTreatmentPlaceboP value

COPD: the comprehensive improvement of pulmonary function, dyspnoea classification, 6-min walking distance and BMI
Chen SQ 2017(stable period)56/6093.3348/6080.000.04
Xie WY 2017(acute period)57/6095.0053/6088.330.19
Shang LZ 201792/10092.0080/10080.000.02
Meta-analysis RR and 95% CI: 1.13 ; I2 = 0%

Diabetic peripheral neuropathy: Pain relief and neurological function improvement
Hu WH 201542/4887.5033/4770.210.04

Depression: Reduction in HAMD Scale ≥25
Liu J 201228/3287.5025/3375.760.23

Angina pectoris: Pain relieved, attacks reduced, ECG improved, nitro-glycerine reduced by 50-80
Pang LJ 201322/2975.8616/2466.670.47

Myasthenia gravis: Reduction of the score of myasthenia gravis scale≥25
Shuang XP 201418/2090.0016/1888.890.91

Herpes simplex keratitis: Symptoms improved and almost normal laboratory test
Song JK 201633/33100.0031/31100.001.00
Song JK 2016a34/34100.0030/3293.750.23

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.